Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_assertion description "[Overexpression of the receptor tyrosine kinase EPH receptor A2 (EphA2) is commonly observed in aggressive breast cancer and correlates with a poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_assertion evidence source_evidence_literature NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_assertion SIO_000772 18079969 NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_assertion wasDerivedFrom befree-20140225 NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_assertion wasGeneratedBy ECO_0000203 NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP728199.RAgnzF2N699PUilY_YvJL5H3zcUcT8t3dm8QjAbBDLWCE130_provenance.